INSP as reported
Inspire Medical Systems, Inc. reported $915M of revenue over the trailing twelve months, +8.9% on the year before. 11 reported series are charted on this page, each one as filed.
$915M
Revenue, trailing twelve months · to Q1 2026 · +8.9% against the twelve months before
- Net Income
- $131M
Net Income · +97% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $97M
Free Cash Flow · +23% year on year · trailing twelve months to Q1 2026
- Op Margin
- 4.8%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $915M | +8.9% | Q1 2026 |
| Net Income | $131M | +97% | Q1 2026 |
| EPS | $4.41 | +103% | Q1 2026 |
| Gross Margin | 86% | n/a | Q1 2026 |
| Op Margin | 4.8% | n/a | Q1 2026 |
| Net Margin | 12% | n/a | Q1 2026 |
| ROE | 12% | n/a | Q1 2026 |
| ROA | 11% | n/a | Q1 2026 |
| ROIC | −70% | n/a | Q4 2022 · 13 quarters behind |
| Free Cash Flow | $97M | +23% | Q1 2026 |
| P/E | 14.0 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Inspire Medical Systems, Inc. (INSP) - Revenue & ProfitRevenue & ProfitInspire Medical Systems, Inc. (INSP)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com